Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine
    Published on 2023-07-12
    2 years ago
  • Are novel treatments for brain disorders hiding in plain sight?
    Published on 2023-07-08
    2 years ago
  • Closing the loop in psychiatric deep brain stimulation: physiology, psychometrics, and plasticity
    Published on 2023-07-06
    2 years ago
  • Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior
    Published on 2023-07-05
    2 years ago
  • Atypical cortical networks in children at high-genetic risk of psychiatric and neurodevelopmental disorders
    Published on 2023-07-04
    2 years ago
  • Transcriptomic profiling of reward and sensory brain areas in perinatal fentanyl exposed juvenile mice
    Published on 2023-07-03
    2 years ago
  • Blocking μ-opioid receptors attenuates reinstatement of responding to an alcohol-predictive conditioned stimulus through actions in the ventral hippocampus
    Published on 2023-07-01
    2 years ago
« Previous 1 … 93 94 95 96 97 … 143 Next »
Journal of Psychopharmacology
  • Histamine H3 receptor gene variants associated with drug abuse in patients with cocaine use disorder
    Published on 2020-10-16
    5 years ago
  • Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking
    Published on 2020-10-16
    5 years ago
  • The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence
    Published on 2020-10-11
    5 years ago
  • Paternal exposure to morphine during adolescence potentiates morphine withdrawal in male offspring: Involvement of the lateral paragigantocellularis nucleus
    Published on 2020-10-09
    5 years ago
  • Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention
    Published on 2020-10-09
    5 years ago
  • Acute subjective effects in LSD- and MDMA-assisted psychotherapy
    Published on 2020-10-09
    5 years ago
  • Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
    Published on 2020-10-09
    5 years ago
« Previous 1 … 93 94 95 96 97 … 134 Next »
European Neuropsychopharmacology
  • Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study
    Published on 2021-04-26
    5 years ago
  • Bipolar disorder cohort studies: Crucial, but underfunded
    Published on 2021-04-23
    5 years ago
  • Anterior cingulate cortex neuro-metabolic changes underlying lithium-induced euthymia in bipolar depression: A longitudinal 1H-MRS study
    Published on 2021-04-19
    5 years ago
  • Editorial
    Published on 2021-04-17
    5 years ago
  • Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise
    Published on 2021-04-13
    5 years ago
  • The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years
    Published on 2021-04-12
    5 years ago
  • Are we ready for precision medicine for Autism? And who wants it?
    Published on 2021-04-12
    5 years ago
« Previous 1 … 93 94 95 96 97 … 154 Next »

   Pharma Pub